COVID-19 Clinical Trials in Chicago

Showing 121-140 of 166 trials

Treatment for COVID-19 in High-Risk Adult Outpatients

NCT04354428

This is a randomized trial for the treatment of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in high-risk adults not requiring hospital admission.The overarching goal of this study is to assess the effectiveness of interventions on the incidence of lower respiratory tract infection (LRTI) progression among high-risk adult outpatients with SARS-CoV-2 infection to inform public health control strategies.

COVID-19SARS-CoV-2

University of Washington289 participantsStarted Apr 2020

Chicago, Illinois, United States • New Orleans, Louisiana, United States • Boston, Massachusetts, United States +3 more locations

COMPLETEDPhase 32.2 miles

Study of Multiple Candidate Agents for the Treatment of COVID-19 in Hospitalized Patients

NCT04590586

The primary objective of this study is to evaluate the time to confirmed clinical recovery in participants hospitalized with COVID-19. Candidate agents will be evaluated frequently for efficacy and safety, with candidate agents being added to and/or removed from the study on an ongoing basis, depending on the results of their evaluation.

COVID-19

Amgen515 participantsStarted Nov 2020

Anniston, Alabama, United States • Bakersfield, California, United States • Chula Vista, California, United States +56 more locations

Treatment for COVID-19 in High-Risk Adult Outpatients

Study of Multiple Candidate Agents for the Treatment of COVID-19 in Hospitalized Patients

COVID-19 Trials in Other Cities

A Study to Evaluate the Efficacy and Safety of Sirukumab in Confirmed Severe or Critical Confirmed Coronavirus Disease (COVID)-19

Tocilizumab to Prevent Clinical Decompensation in Hospitalized, Non-critically Ill Patients With COVID-19 Pneumonitis

Adaptive COVID-19 Treatment Trial (ACTT)

COVID-19 Positive Outpatient Thrombosis Prevention in Adults Aged 40-80

Dapagliflozin in Respiratory Failure in Patients With COVID-19

Convalescent Plasma to Stem Coronavirus (CSSC-001)

A Study to Investigate Intravenous Tocilizumab in Participants With Moderate to Severe COVID-19 Pneumonia

COVID-19 Progression in End-Stage Kidney Disease

A Study of Opaganib in Coronavirus Disease 2019 Pneumonia

CONvalescent Plasma for Hospitalized Adults With COVID-19 Respiratory Illness (CONCOR-1)

InterLeukin-7 to Improve Clinical Outcomes in Lymphopenic pAtients With COVID-19 Infection ( ILIAD-7-US-I )

Inpatient Treatment of COVID-19 With Anti-Coronavirus Immunoglobulin (ITAC)

A Study of Immune Responses to the Virus That Causes COVID-19

Expanded Access Remdesivir (RDV; GS-5734™)

COVID-19 Vaccines Safety Tracking (CoVaST)

Safety, Tolerability, and Pharmacokinetics of SAB-185 in Healthy Participants

Study of the Use of Favipiravir in Hospitalized Subjects With COVID-19

Prone Positioning Short-term Effects on Tissue Oxygen Saturation in Critical COVID-19 Patients

Other Conditions in Chicago